Kevin M. Picardat

Array ( [id] => 800387 [patent_doc_number] => 07425531 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'Bone polypeptide-1' [patent_app_type] => utility [patent_app_number] => 10/499762 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 12 [patent_no_of_words] => 21021 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425531.pdf [firstpage_image] =>[orig_patent_app_number] => 10499762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999485 [patent_doc_number] => 06911334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-28 [patent_title] => 'Protease for activating clotting factor VII' [patent_app_type] => utility [patent_app_number] => 10/319592 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9620 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911334.pdf [firstpage_image] =>[orig_patent_app_number] => 10319592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7010299 [patent_doc_number] => 20050064015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Methods and compositions for use in pet breeding' [patent_app_type] => utility [patent_app_number] => 10/497714 [patent_app_country] => US [patent_app_date] => 2002-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3627 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064015.pdf [firstpage_image] =>[orig_patent_app_number] => 10497714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851998 [patent_doc_number] => 20030144201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Use of HMGB fragments as anti-inflammatory agents' [patent_app_type] => new [patent_app_number] => 10/300072 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 21944 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144201.pdf [firstpage_image] =>[orig_patent_app_number] => 10300072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1040634 [patent_doc_number] => 06869932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-22 [patent_title] => 'Site-specific preparation of polyethlene glycol-GRF conjugates' [patent_app_type] => utility [patent_app_number] => 10/299790 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 9795 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/869/06869932.pdf [firstpage_image] =>[orig_patent_app_number] => 10299790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822329 [patent_doc_number] => 20030220490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Cell membrane directed drugs' [patent_app_type] => new [patent_app_number] => 10/298796 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20319 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220490.pdf [firstpage_image] =>[orig_patent_app_number] => 10298796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 462490 [patent_doc_number] => 07238357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Methods for treating ulcers and gastroesophageal reflux disease' [patent_app_type] => utility [patent_app_number] => 10/288734 [patent_app_country] => US [patent_app_date] => 2002-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13522 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238357.pdf [firstpage_image] =>[orig_patent_app_number] => 10288734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 951447 [patent_doc_number] => 06960652 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-01 [patent_title] => 'Compositions and methods for modifying toxic effects of proteinaceous compounds' [patent_app_type] => utility [patent_app_number] => 10/282935 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 31134 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/960/06960652.pdf [firstpage_image] =>[orig_patent_app_number] => 10282935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6987148 [patent_doc_number] => 20050086822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'High throughput isolation of biological compounds' [patent_app_type] => utility [patent_app_number] => 10/493842 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13430 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20050086822.pdf [firstpage_image] =>[orig_patent_app_number] => 10493842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860598 [patent_doc_number] => 20030091606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators' [patent_app_type] => new [patent_app_number] => 10/281652 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7885 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091606.pdf [firstpage_image] =>[orig_patent_app_number] => 10281652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 582680 [patent_doc_number] => 07449446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Combination product comprising melagatran and dexamethasone' [patent_app_type] => utility [patent_app_number] => 10/493625 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5773 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449446.pdf [firstpage_image] =>[orig_patent_app_number] => 10493625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856673 [patent_doc_number] => 20030130174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/273823 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11251 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130174.pdf [firstpage_image] =>[orig_patent_app_number] => 10273823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851459 [patent_doc_number] => 20030143662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/278594 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11310 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143662.pdf [firstpage_image] =>[orig_patent_app_number] => 10278594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169929 [patent_doc_number] => 20050202527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Thrombin-cleavable chimeric proteins' [patent_app_type] => utility [patent_app_number] => 10/492191 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17776 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202527.pdf [firstpage_image] =>[orig_patent_app_number] => 10492191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005439 [patent_doc_number] => 06906035 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-14 [patent_title] => 'Antimicrobial cationic peptides' [patent_app_type] => utility [patent_app_number] => 10/272248 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 14769 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/906/06906035.pdf [firstpage_image] =>[orig_patent_app_number] => 10272248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 968670 [patent_doc_number] => 06939945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-06 [patent_title] => 'Synthetic peptides, conjugation reagents and methods' [patent_app_type] => utility [patent_app_number] => 10/268813 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13454 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/939/06939945.pdf [firstpage_image] =>[orig_patent_app_number] => 10268813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966015 [patent_doc_number] => 20050232912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Enzyme phosphorylating ser46 of p53' [patent_app_type] => utility [patent_app_number] => 10/490454 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4162 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232912.pdf [firstpage_image] =>[orig_patent_app_number] => 10490454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792463 [patent_doc_number] => 20030087807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity' [patent_app_type] => new [patent_app_number] => 10/255536 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19136 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087807.pdf [firstpage_image] =>[orig_patent_app_number] => 10255536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7338046 [patent_doc_number] => 20040132957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Precursors of silk-like materials, silk-like materials and processes for producing both' [patent_app_type] => new [patent_app_number] => 10/239399 [patent_app_country] => US [patent_app_date] => 2002-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4120 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132957.pdf [firstpage_image] =>[orig_patent_app_number] => 10239399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034175 [patent_doc_number] => 20050032685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Remedies for bone loss' [patent_app_type] => utility [patent_app_number] => 10/489776 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5145 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032685.pdf [firstpage_image] =>[orig_patent_app_number] => 10489776 [rel_patent_id] =>[rel_patent_doc_number] =>)